| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
181,878 |
167,434 |
$24.09M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
24,960 |
24,894 |
$1.16M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
24,542 |
23,892 |
$1.01M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
172,864 |
156,328 |
$932K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14,411 |
14,376 |
$817K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
16,669 |
16,040 |
$616K |
| 92551 |
|
27,475 |
27,329 |
$552K |
| G9920 |
Screening performed and negative |
9,940 |
9,937 |
$411K |
| 90686 |
|
26,787 |
26,515 |
$352K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,637 |
21,389 |
$205K |
| 99173 |
|
27,348 |
27,210 |
$171K |
| 90670 |
|
9,040 |
8,771 |
$117K |
| 90648 |
|
8,976 |
8,717 |
$114K |
| 85018 |
|
43,043 |
42,161 |
$97K |
| 90651 |
|
6,109 |
6,091 |
$85K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
912 |
911 |
$84K |
| 90633 |
|
6,414 |
6,148 |
$82K |
| 90723 |
|
6,003 |
5,932 |
$76K |
| 90680 |
|
5,855 |
5,800 |
$75K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,204 |
2,143 |
$66K |
| 90710 |
|
3,291 |
3,273 |
$50K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,927 |
1,927 |
$48K |
| 90716 |
|
3,323 |
3,133 |
$47K |
| 90734 |
|
3,479 |
3,472 |
$47K |
| 90715 |
|
3,342 |
3,335 |
$44K |
| 90696 |
|
3,326 |
3,309 |
$44K |
| 90707 |
|
3,121 |
2,937 |
$41K |
| 90620 |
|
2,862 |
2,859 |
$40K |
| 90700 |
|
2,926 |
2,840 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13,630 |
12,909 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,594 |
3,553 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,640 |
2,610 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
777 |
728 |
$25K |
| 99188 |
|
1,091 |
1,086 |
$25K |
| 90697 |
|
1,664 |
1,598 |
$23K |
| 90619 |
|
1,590 |
1,589 |
$22K |
| 90677 |
|
1,179 |
1,178 |
$21K |
| 90656 |
|
1,368 |
1,368 |
$20K |
| 90688 |
|
1,241 |
1,238 |
$17K |
| 99381 |
|
226 |
221 |
$17K |
| 86580 |
|
3,583 |
3,488 |
$17K |
| 83655 |
|
1,208 |
1,205 |
$16K |
| H0049 |
Alcohol and/or drug screening |
377 |
377 |
$14K |
| 0082A |
|
196 |
196 |
$13K |
| 90685 |
|
765 |
759 |
$13K |
| 90681 |
|
941 |
890 |
$13K |
| 99215 |
Prolong outpt/office vis |
294 |
287 |
$11K |
| 99000 |
|
2,847 |
2,718 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
333 |
331 |
$10K |
| 0072A |
|
130 |
130 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
209 |
208 |
$8K |
| 81002 |
|
3,689 |
3,509 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
210 |
189 |
$6K |
| 88720 |
|
1,737 |
1,203 |
$6K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
101 |
101 |
$6K |
| 90671 |
|
368 |
368 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
423 |
376 |
$5K |
| 0124A |
|
64 |
64 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
173 |
172 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,443 |
1,294 |
$4K |
| 0081A |
|
48 |
48 |
$3K |
| 87807 |
|
394 |
391 |
$3K |
| 90381 |
|
176 |
157 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
409 |
379 |
$2K |
| 0071A |
|
32 |
32 |
$2K |
| 0173A |
|
26 |
26 |
$2K |
| 0074A |
|
26 |
26 |
$2K |
| 69210 |
|
776 |
391 |
$2K |
| 0054A |
|
14 |
14 |
$938.00 |
| 0154A |
|
13 |
13 |
$871.00 |
| 91319 |
|
91 |
51 |
$695.00 |
| 81025 |
|
178 |
173 |
$613.15 |
| 90744 |
|
45 |
43 |
$584.86 |
| 90380 |
|
36 |
35 |
$486.00 |
| 90480 |
|
13 |
13 |
$416.00 |
| 90732 |
|
26 |
26 |
$355.50 |
| 94010 |
|
13 |
13 |
$287.82 |
| 90756 |
|
16 |
16 |
$287.00 |
| 82947 |
|
64 |
64 |
$245.28 |
| 90713 |
|
16 |
16 |
$216.00 |
| 91318 |
|
13 |
12 |
$182.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,352 |
1,227 |
$167.53 |
| 91321 |
|
12 |
12 |
$162.00 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
12 |
12 |
$120.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
61 |
61 |
$49.06 |
| 81003 |
|
19 |
19 |
$36.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
15 |
$0.00 |